(FIHL) Fidelis Insurance Holdings - Overview
Sector: Financial ServicesIndustry: Insurance - Diversified | Exchange NYSE (USA) | Currency USD | Market Cap: 1.653m | Total Return 23.2% in 12m
Stock: Property, Marine, Aviation, Energy, Cyber
Total Rating 51
Risk 63
Buy Signal 0.59
| Risk 5d forecast | |
|---|---|
| Volatility | 29.7% |
| Relative Tail Risk | -6.27% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.78 |
| Alpha | 12.82 |
| Character TTM | |
|---|---|
| Beta | 0.713 |
| Beta Downside | 1.018 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.91% |
| CAGR/Max DD | 0.61 |
EPS (Earnings per Share)
Revenue
Description: FIHL Fidelis Insurance Holdings March 04, 2026
Fidelis Insurance Holdings Limited (FIHL) is an insurance and reinsurance company operating in Bermuda, Ireland, and the UK. The company specializes in property and casualty insurance, a sector focused on protecting assets and managing liability risks.
FIHLs business model is divided into two segments: Insurance and Reinsurance. The Insurance segment offers diverse products including property, marine, aviation, and cyber coverage. The Reinsurance segment provides solutions such as property, retrocession, and whole account reinsurance, which involves insurers transferring portions of their risk portfolios to other insurers.
Founded in 2014 and headquartered in Bermuda, FIHL operates within the global insurance market, a complex industry characterized by cyclical premium pricing and significant capital requirements. For a deeper dive into financial performance and competitive positioning, consider exploring ValueRays comprehensive analytics.
Headlines to watch out for
- Catastrophe events increase reinsurance demand and pricing
- Investment income volatility impacts overall profitability
- Regulatory changes in Bermuda, Ireland, UK affect operations
- Competition in specialty insurance and reinsurance segments intensifies
- Global economic conditions influence premium growth and claims
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 225.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.04 > 0.02 and ΔFCF/TA -9.59 > 1.0 |
| NWC/Revenue: -180.0% < 20% (prev 26.13%; Δ -206.1% < -1%) |
| CFO/TA -0.04 > 3% & CFO -408.3m > Net Income 225.5m |
| Net Debt (-404.4m) to EBITDA (323.3m): -1.25 < 3 |
| Current Ratio: 0.52 > 1.5 & < 3 |
| Outstanding Shares: last quarter (101.1m) vs 12m ago -9.54% < -2% |
| Gross Margin: 27.12% > 18% (prev 0.45%; Δ 2.67k% > 0.5%) |
| Asset Turnover: 22.90% > 50% (prev 19.93%; Δ 2.97% > 0%) |
| Interest Coverage Ratio: 5.78 > 6 (EBITDA TTM 323.3m / Interest Expense TTM 47.7m) |
Altman Z'' -2.53
| A: -0.46 (Total Current Assets 4.74b - Total Current Liabilities 9.10b) / Total Assets 9.37b |
| B: 0.07 (Retained Earnings 675.9m / Total Assets 9.37b) |
| C: 0.03 (EBIT TTM 275.6m / Avg Total Assets 10.57b) |
| D: 0.10 (Book Value of Equity 714.0m / Total Liabilities 6.97b) |
| Altman-Z'' Score: -2.53 = D |
Beneish M
| DSRI: 0.76 (Receivables 3.50b/4.47b, Revenue 2.42b/2.34b) |
| GMI: 1.66 (GM 27.12% / 44.97%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.03 (Revenue 2.42b / 2.34b) |
| TATA: 0.07 (NI 225.5m - CFO -408.3m) / TA 9.37b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of FIHL shares?
As of March 28, 2026, the stock is trading at USD 19.17 with a total of 254,492 shares traded.
Over the past week, the price has changed by +2.73%, over one month by +0.34%, over three months by -0.80% and over the past year by +23.19%.
Over the past week, the price has changed by +2.73%, over one month by +0.34%, over three months by -0.80% and over the past year by +23.19%.
Is FIHL a buy, sell or hold?
Fidelis Insurance Holdings has received a consensus analysts rating of 3.33.
Therefor, it is recommend to hold FIHL.
- StrongBuy: 1
- Buy: 2
- Hold: 5
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the FIHL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 22 | 14.8% |
| Analysts Target Price | 22 | 14.8% |
FIHL Fundamental Data Overview March 27, 2026
P/E Trailing = 9.0569
P/E Forward = 5.9488
P/S = 0.6609
P/B = 0.6842
Revenue TTM = 2.42b USD
EBIT TTM = 275.6m USD
EBITDA TTM = 323.3m USD
Long Term Debt = 843.2m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 843.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -404.4m USD (from netDebt column, last quarter)
Enterprise Value = 1.25b USD (1.65b + Debt 843.2m - CCE 1.25b)
Interest Coverage Ratio = 5.78 (Ebit TTM 275.6m / Interest Expense TTM 47.7m)
EV/FCF = -3.05x (Enterprise Value 1.25b / FCF TTM -409.5m)
FCF Yield = -32.81% (FCF TTM -409.5m / Enterprise Value 1.25b)
FCF Margin = -16.92% (FCF TTM -409.5m / Revenue TTM 2.42b)
Net Margin = 9.32% (Net Income TTM 225.5m / Revenue TTM 2.42b)
Gross Margin = 27.12% ((Revenue TTM 2.42b - Cost of Revenue TTM 1.76b) / Revenue TTM)
Gross Margin QoQ = 69.51% (prev 31.24%)
Tobins Q-Ratio = 0.13 (Enterprise Value 1.25b / Total Assets 9.37b)
Interest Expense / Debt = 1.73% (Interest Expense 14.6m / Debt 843.2m)
Taxrate = 17.56% (25.1m / 142.9m)
NOPAT = 227.2m (EBIT 275.6m * (1 - 17.56%))
Current Ratio = 0.52 (Total Current Assets 4.74b / Total Current Liabilities 9.10b)
Debt / Equity = 0.35 (Debt 843.2m / totalStockholderEquity, last quarter 2.40b)
Debt / EBITDA = -1.25 (Net Debt -404.4m / EBITDA 323.3m)
Debt / FCF = 0.99 (negative FCF - burning cash) (Net Debt -404.4m / FCF TTM -409.5m)
Total Stockholder Equity = 2.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.13% (Net Income 225.5m / Total Assets 9.37b)
RoE = 9.46% (Net Income TTM 225.5m / Total Stockholder Equity 2.38b)
RoCE = 8.54% (EBIT 275.6m / Capital Employed (Equity 2.38b + L.T.Debt 843.2m))
RoIC = 7.27% (NOPAT 227.2m / Invested Capital 3.13b)
WACC = 6.10% (E(1.65b)/V(2.50b) * Re(8.49%) + D(843.2m)/V(2.50b) * Rd(1.73%) * (1-Tc(0.18)))
Discount Rate = 8.49% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -7.55%
[DCF] Fair Price = unknown (Cash Flow -409.5m)
EPS Correlation: -22.44 | EPS CAGR: 8.54% | SUE: 0.72 | # QB: 0
Revenue Correlation: 9.92 | Revenue CAGR: 18.61% | SUE: -0.12 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.88 | Chg7d=+0.005 | Chg30d=-0.017 | Revisions Net=-1 | Analysts=8
EPS current Year (2026-12-31): EPS=3.40 | Chg7d=-0.028 | Chg30d=-0.239 | Revisions Net=-7 | Growth EPS=+77.3% | Growth Revenue=+24.2%
EPS next Year (2027-12-31): EPS=3.97 | Chg7d=+0.033 | Chg30d=-0.038 | Revisions Net=-2 | Growth EPS=+16.6% | Growth Revenue=+6.9%
[Analyst] Revisions Ratio: -0.20 (2 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -2.6% (Discount Rate 8.5% - Earnings Yield 11.0%)
[Growth] Growth Spread = +20.9% (Analyst 18.4% - Implied -2.6%)
P/E Forward = 5.9488
P/S = 0.6609
P/B = 0.6842
Revenue TTM = 2.42b USD
EBIT TTM = 275.6m USD
EBITDA TTM = 323.3m USD
Long Term Debt = 843.2m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 843.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -404.4m USD (from netDebt column, last quarter)
Enterprise Value = 1.25b USD (1.65b + Debt 843.2m - CCE 1.25b)
Interest Coverage Ratio = 5.78 (Ebit TTM 275.6m / Interest Expense TTM 47.7m)
EV/FCF = -3.05x (Enterprise Value 1.25b / FCF TTM -409.5m)
FCF Yield = -32.81% (FCF TTM -409.5m / Enterprise Value 1.25b)
FCF Margin = -16.92% (FCF TTM -409.5m / Revenue TTM 2.42b)
Net Margin = 9.32% (Net Income TTM 225.5m / Revenue TTM 2.42b)
Gross Margin = 27.12% ((Revenue TTM 2.42b - Cost of Revenue TTM 1.76b) / Revenue TTM)
Gross Margin QoQ = 69.51% (prev 31.24%)
Tobins Q-Ratio = 0.13 (Enterprise Value 1.25b / Total Assets 9.37b)
Interest Expense / Debt = 1.73% (Interest Expense 14.6m / Debt 843.2m)
Taxrate = 17.56% (25.1m / 142.9m)
NOPAT = 227.2m (EBIT 275.6m * (1 - 17.56%))
Current Ratio = 0.52 (Total Current Assets 4.74b / Total Current Liabilities 9.10b)
Debt / Equity = 0.35 (Debt 843.2m / totalStockholderEquity, last quarter 2.40b)
Debt / EBITDA = -1.25 (Net Debt -404.4m / EBITDA 323.3m)
Debt / FCF = 0.99 (negative FCF - burning cash) (Net Debt -404.4m / FCF TTM -409.5m)
Total Stockholder Equity = 2.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.13% (Net Income 225.5m / Total Assets 9.37b)
RoE = 9.46% (Net Income TTM 225.5m / Total Stockholder Equity 2.38b)
RoCE = 8.54% (EBIT 275.6m / Capital Employed (Equity 2.38b + L.T.Debt 843.2m))
RoIC = 7.27% (NOPAT 227.2m / Invested Capital 3.13b)
WACC = 6.10% (E(1.65b)/V(2.50b) * Re(8.49%) + D(843.2m)/V(2.50b) * Rd(1.73%) * (1-Tc(0.18)))
Discount Rate = 8.49% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -7.55%
[DCF] Fair Price = unknown (Cash Flow -409.5m)
EPS Correlation: -22.44 | EPS CAGR: 8.54% | SUE: 0.72 | # QB: 0
Revenue Correlation: 9.92 | Revenue CAGR: 18.61% | SUE: -0.12 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.88 | Chg7d=+0.005 | Chg30d=-0.017 | Revisions Net=-1 | Analysts=8
EPS current Year (2026-12-31): EPS=3.40 | Chg7d=-0.028 | Chg30d=-0.239 | Revisions Net=-7 | Growth EPS=+77.3% | Growth Revenue=+24.2%
EPS next Year (2027-12-31): EPS=3.97 | Chg7d=+0.033 | Chg30d=-0.038 | Revisions Net=-2 | Growth EPS=+16.6% | Growth Revenue=+6.9%
[Analyst] Revisions Ratio: -0.20 (2 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -2.6% (Discount Rate 8.5% - Earnings Yield 11.0%)
[Growth] Growth Spread = +20.9% (Analyst 18.4% - Implied -2.6%)